Denali Reverses Its Fortunes With 'Too Early' Miss In ALS Treatment
In This Article:
Denali Therapeutics shares reversed higher on Tuesday after the drugmaker's ALS treatment failed in a six-month study.
Oops, something went wrong
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Denali Therapeutics shares reversed higher on Tuesday after the drugmaker's ALS treatment failed in a six-month study.